When a patient is on Dilantin (phenytoin) and Depakote (valproic acid), which blood test is necessary?

When a patient is on Dilantin (phenytoin) and Depakote (valproic acid), which blood test is necessary?

• A. Liver function test
• B. Complete blood count (CBC)
• C. Electrolyte panel
• D. Thyroid function test

Answer: (B)

The necessity for a complete blood count (CBC) in a patient on Dilantin (phenytoin) and Depakote (valproic acid) arises from the potential hematological side effects associated with both medications. Phenytoin is known to cause various blood-related issues, including leukopenia, thrombocytopenia, and megaloblastic anemia due to impaired folate metabolism. Regular monitoring through a CBC helps to identify any significant changes in the blood cell counts that may arise from the use of this medication. Valproic acid also has a profile of possible side effects that affect blood cell lines, including hepatotoxicity and suppression of platelet production, leading to thrombocytopenia. Monitoring the CBC is essential to ensure that platelets and white blood cell counts remain within acceptable ranges, thus preventing complications related to decreased immunity and increased bleeding risk. While liver function tests are important for monitoring the effects of these medications on the liver, the more immediate concern with respect to blood health stems from the potential blood dyscrasias caused by both drugs, making the CBC critical in this scenario.

The necessity for a complete blood count (CBC) in a patient on Dilantin (phenytoin) and Depakote (valproic acid) arises from the potential hematological side effects associated with both medications.

Phenytoin is known to cause various blood-related issues, including leukopenia, thrombocytopenia, and megaloblastic anemia due to impaired folate metabolism. Regular monitoring through a CBC helps to identify any significant changes in the blood cell counts that may arise from the use of this medication.

Valproic acid also has a profile of possible side effects that affect blood cell lines, including hepatotoxicity and suppression of platelet production, leading to thrombocytopenia. Monitoring the CBC is essential to ensure that platelets and white blood cell counts remain within acceptable ranges, thus preventing complications related to decreased immunity and increased bleeding risk.

While liver function tests are important for monitoring the effects of these medications on the liver, the more immediate concern with respect to blood health stems from the potential blood dyscrasias caused by both drugs, making the CBC critical in this scenario.